Filtered Listing Testing
BrightFocus Foundation today announced that it has received a SHORTY Social Good Award® for the public impact of its nationwide screening tour of Turning Point, a documentary by acclaimed filmmaker James Keach.
In a new Gates Notes, philanthropist Bill Gates outlined the great challenges facing scientists in the search for better treatments, and ultimately a cure, for Alzheimer’s disease.
Learn about groundbreaking discoveries from scientists funded by Macular Degeneration Research that presented their research at the annual meeting of the Association for Research in Vision and Ophthalmology, a cellular nutrient that could help delay macular degeneration, how environmental stressors damage the retina, tips to help yourself and others adapt to low vision, and more in the fall 2019 edition of Macular Degeneration News.
BrightFocus is highly encouraged by Biogen’s announcement today that clinical trials of its experimental drug aducanumab reduced cognitive decline in some Alzheimer’s patients through improved cognition, memory, and activities of daily living.
The BrightFocus Glaucoma Fast Track Workshop is a day-long workshop providing a unique immersive environment for early-stage scientists focused on glaucoma research or those who want to enter the field to accelerate their path towards becoming an expert in this exciting field.
BrightFocus is once again leading Alzheimer’s Fast Track, a several day incubator for some of the world’s most promising early career researchers. By encouraging and supporting these women and men, BrightFocus hopes to accelerate the path to a cure for the disease.
The fall 2019 edition of Alzheimer's Disease Research Review explores research why glucose uptake is reduced in Alzheimer’s disease, a scientist who is exploring a retinal “fingerprint” that might provide early detection of Alzheimer’s, how a new genetic diversity model can revolutionizing Alzheimer’s research, and more.